<DOC>
	<DOCNO>NCT02971826</DOCNO>
	<brief_summary>The last marketed thrombectomy device , name stentretriever , permit good fast recanalization patient stroke . The REVIVETM SE device design restore brain perfusion patient intracranial artery occlusion . The REVIVETM Se device widely use Europe France . The objective study assess interest use device standard care ischemic stroke radiology unit hospital Pierre Wertheimer , Lyon . The medical care modify data collect order determine whether device useful practice radiology unit .</brief_summary>
	<brief_title>Use Thrombectomy Device ReVive™ SE Acute Treatment Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<criteria>Patient ischemic stroke detect Computed Tomography ( CT ) Magnetic Resonance Image ( MRI ) Large proximal arterial occlusion : M1 segment Middle cerebral artery ( MCA ) , Internal Carotid Artery ( ICA ) Basilar Artery ( BA ) Last know well ( without neurological symptom ) ≤ 8 hour treatment initiation Score NIHSS ≥4 Eligibility endovascular procedure use REVIVETM SE device No opposition patient participate study Diagnostic cerebral image impossible Distal occlusion Tortuous vessel specificity prevent access device Vessel diameter &lt; 1.5 mm Known hypersensibility allergy nitinol Subjects cover right social security Deprivation civil right ( guardianship , safeguard justice )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Stroke</keyword>
	<keyword>thrombectomy</keyword>
	<keyword>REVIVETM SE</keyword>
	<keyword>MRI</keyword>
	<keyword>Computed Tomography</keyword>
</DOC>